Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Analysis of Cathepsin B (total) (Human) by ELISA (CAT#: STEM-MB-0716-LGZ)

Introduction

Cathepsin, a papain-like cysteine or aspartic acid protease, is ubiquitously present in lysosome organelles, activated in an acidic environment, and cleaves various target proteins. According to their structure and substrate specificity, there are about ten kinds of members in the cathepsin family, including A, B, C, D, E, G, H, K, L, S and so on. Cathepsins play an important role in the turnover of intracellular and extracellular proteins through endocytosis, as well as an alternative mechanism for initiating and transmitting signals of apoptosis, as well as pathophysiological changes of tumor and inflammatory tissue damage.
Among them, hispsin B (EC 3.4.22.1), also known as CTSB, as the signature enzyme protein of lysosome, can transform β-amyloid precursor protein into β-amyloid protein spots, which play an important role in antigen processing, tumor metastasis, bone reabsorption, intracellular or secretory regulation of protein turnover, egg cell maturation, cell apoptosis, etc. Intercellular contact and extracellular matrix components affect the conversion of 43kd cathepsinogen L into mature proteins. Cathepsin B degrades collagen, connective tissue protein and beta-amyloid precursor protein. It interacts with cysteine protease inhibitors A and B, S100A10 and other proteins. Abnormal cathepsin B can lead to diseases such as Alzheimer's syndrome and esophageal tumors.




Principle

Enzyme-linked immunosorbent assay (ELISA) is an enzyme-labeled solid phase immunoassay technique. Its basic principle is to bind the antigen (or antibody) to the solid phase carrier, and the antigen (or antibody) and a certain enzyme link to enzyme labeled antigen (or antibody). During detection, the sample to be tested and the enzymic antigen (or antibody) react with the antigen (or antibody) on the solid phase carrier according to certain procedures, and then remove the unreacted part by washing method. After adding the substrate, the substrate is catalyzed by the enzyme on the solid phase carrier to produce colored substances. Through qualitative or quantitative detection of the amount of colored products, the content of the substance to be measured in the sample can be determined.

Applications

Alzheimer's syndrome and esophageal tumors.

Procedure

1. Add standards or samples to each well and incubate.
2. Pour off the liquid in the well, biotinylated antibody working solution and incubate.
3. Add enzyme conjugate working solution and incubate.
4. Add substrate TMB and incubate.
5. Add stop solution and measure OD value.
6. Calculation of results.

Materials

• Sample Type: Cell culture supernatant, Cell Lysate, Other biological fluids, Plasma, Serum, Tissue Extracts
Advertisement